nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR1—hypertension	0.133	0.385	CbGaD
Ponatinib—SRC—hypertension	0.0848	0.245	CbGaD
Ponatinib—KDR—hypertension	0.0797	0.231	CbGaD
Ponatinib—CYP3A5—hypertension	0.0481	0.139	CbGaD
Ponatinib—ABCB11—Reserpine—hypertension	0.0228	0.0678	CbGbCtD
Ponatinib—ABCB11—Verapamil—hypertension	0.00898	0.0267	CbGbCtD
Ponatinib—ABCG2—Telmisartan—hypertension	0.00865	0.0258	CbGbCtD
Ponatinib—ABCG2—Prazosin—hypertension	0.00783	0.0233	CbGbCtD
Ponatinib—CYP2C8—Torasemide—hypertension	0.00696	0.0207	CbGbCtD
Ponatinib—CYP2C8—Candesartan—hypertension	0.00647	0.0193	CbGbCtD
Ponatinib—CYP3A5—Reserpine—hypertension	0.006	0.0179	CbGbCtD
Ponatinib—CYP3A5—Nisoldipine—hypertension	0.00528	0.0157	CbGbCtD
Ponatinib—ABCB1—Nadolol—hypertension	0.00515	0.0153	CbGbCtD
Ponatinib—CYP3A5—Eplerenone—hypertension	0.0051	0.0152	CbGbCtD
Ponatinib—CYP3A5—Diltiazem—hypertension	0.0051	0.0152	CbGbCtD
Ponatinib—CYP2C8—Diltiazem—hypertension	0.0049	0.0146	CbGbCtD
Ponatinib—CYP2D6—Labetalol—hypertension	0.00485	0.0144	CbGbCtD
Ponatinib—CYP2D6—Nebivolol—hypertension	0.00485	0.0144	CbGbCtD
Ponatinib—ABCB1—Acebutolol—hypertension	0.00471	0.014	CbGbCtD
Ponatinib—CYP2D6—Acebutolol—hypertension	0.00444	0.0132	CbGbCtD
Ponatinib—ABCB1—Metoprolol—hypertension	0.00438	0.013	CbGbCtD
Ponatinib—ABCB1—Candesartan—hypertension	0.00438	0.013	CbGbCtD
Ponatinib—ABCG2—Verapamil—hypertension	0.00427	0.0127	CbGbCtD
Ponatinib—CYP2D6—Pindolol—hypertension	0.00413	0.0123	CbGbCtD
Ponatinib—CYP2D6—Metoprolol—hypertension	0.00413	0.0123	CbGbCtD
Ponatinib—ABCB1—Terazosin—hypertension	0.00412	0.0123	CbGbCtD
Ponatinib—CYP3A5—Amlodipine—hypertension	0.00408	0.0121	CbGbCtD
Ponatinib—CYP3A4—Guanethidine—hypertension	0.00407	0.0121	CbGbCtD
Ponatinib—CYP2C8—Irbesartan—hypertension	0.004	0.0119	CbGbCtD
Ponatinib—CYP3A5—Felodipine—hypertension	0.00393	0.0117	CbGbCtD
Ponatinib—CYP2C8—Amlodipine—hypertension	0.00392	0.0117	CbGbCtD
Ponatinib—ABCB1—Reserpine—hypertension	0.0039	0.0116	CbGbCtD
Ponatinib—CYP2C8—Spironolactone—hypertension	0.00385	0.0115	CbGbCtD
Ponatinib—CYP3A5—Nifedipine—hypertension	0.0038	0.0113	CbGbCtD
Ponatinib—CYP2C8—Felodipine—hypertension	0.00378	0.0112	CbGbCtD
Ponatinib—CYP3A5—Nicardipine—hypertension	0.00374	0.0111	CbGbCtD
Ponatinib—CYP2D6—Betaxolol—hypertension	0.00368	0.0109	CbGbCtD
Ponatinib—CYP2C8—Nifedipine—hypertension	0.00366	0.0109	CbGbCtD
Ponatinib—CYP2C8—Nicardipine—hypertension	0.0036	0.0107	CbGbCtD
Ponatinib—ABCB1—Perindopril—hypertension	0.00357	0.0106	CbGbCtD
Ponatinib—CYP3A5—Propranolol—hypertension	0.00344	0.0103	CbGbCtD
Ponatinib—ABCB1—Doxazosin—hypertension	0.00344	0.0102	CbGbCtD
Ponatinib—ABCB1—Nisoldipine—hypertension	0.00344	0.0102	CbGbCtD
Ponatinib—ABCB1—Diltiazem—hypertension	0.00332	0.00988	CbGbCtD
Ponatinib—CYP3A5—Clonidine—hypertension	0.00329	0.00978	CbGbCtD
Ponatinib—CYP2D6—Doxazosin—hypertension	0.00324	0.00964	CbGbCtD
Ponatinib—CYP2D6—Diltiazem—hypertension	0.00313	0.00931	CbGbCtD
Ponatinib—ABCB1—Telmisartan—hypertension	0.00312	0.00929	CbGbCtD
Ponatinib—CYP3A4—Hydralazine—hypertension	0.00309	0.00918	CbGbCtD
Ponatinib—ABCB1—Bepridil—hypertension	0.00296	0.0088	CbGbCtD
Ponatinib—ABCB1—Enalapril—hypertension	0.00296	0.0088	CbGbCtD
Ponatinib—ABCB1—Lisinopril—hypertension	0.00296	0.0088	CbGbCtD
Ponatinib—CYP3A5—Atorvastatin—hypertension	0.00293	0.00872	CbGbCtD
Ponatinib—ABCB1—Prazosin—hypertension	0.00282	0.0084	CbGbCtD
Ponatinib—CYP2C8—Atorvastatin—hypertension	0.00282	0.00838	CbGbCtD
Ponatinib—CYP2D6—Bepridil—hypertension	0.00279	0.0083	CbGbCtD
Ponatinib—CYP3A5—Losartan—hypertension	0.00268	0.00797	CbGbCtD
Ponatinib—ABCB1—Amlodipine—hypertension	0.00265	0.0079	CbGbCtD
Ponatinib—CYP3A4—Guanfacine—hypertension	0.00262	0.00781	CbGbCtD
Ponatinib—ABCB1—Spironolactone—hypertension	0.0026	0.00775	CbGbCtD
Ponatinib—CYP2C8—Losartan—hypertension	0.00258	0.00767	CbGbCtD
Ponatinib—ABCB1—Felodipine—hypertension	0.00256	0.00761	CbGbCtD
Ponatinib—CYP2D6—Irbesartan—hypertension	0.00255	0.00759	CbGbCtD
Ponatinib—ABCB1—Timolol—hypertension	0.00252	0.00749	CbGbCtD
Ponatinib—CYP2D6—Amlodipine—hypertension	0.0025	0.00744	CbGbCtD
Ponatinib—ABCB1—Nifedipine—hypertension	0.00247	0.00736	CbGbCtD
Ponatinib—ABCB1—Nicardipine—hypertension	0.00244	0.00725	CbGbCtD
Ponatinib—ABCB1—Carvedilol—hypertension	0.00244	0.00725	CbGbCtD
Ponatinib—CYP2D6—Felodipine—hypertension	0.00241	0.00717	CbGbCtD
Ponatinib—CYP2D6—Timolol—hypertension	0.00237	0.00705	CbGbCtD
Ponatinib—CYP3A5—Verapamil—hypertension	0.00236	0.00704	CbGbCtD
Ponatinib—CYP3A4—Isradipine—hypertension	0.00234	0.00696	CbGbCtD
Ponatinib—CYP2D6—Nifedipine—hypertension	0.00233	0.00694	CbGbCtD
Ponatinib—CYP2D6—Carvedilol—hypertension	0.0023	0.00683	CbGbCtD
Ponatinib—CYP2D6—Nicardipine—hypertension	0.0023	0.00683	CbGbCtD
Ponatinib—CYP2C8—Verapamil—hypertension	0.00227	0.00677	CbGbCtD
Ponatinib—ABCB1—Propranolol—hypertension	0.00224	0.00667	CbGbCtD
Ponatinib—ABCB1—Captopril—hypertension	0.00221	0.00659	CbGbCtD
Ponatinib—ABCB1—Clonidine—hypertension	0.00214	0.00637	CbGbCtD
Ponatinib—CYP2D6—Propranolol—hypertension	0.00211	0.00629	CbGbCtD
Ponatinib—CYP2D6—Captopril—hypertension	0.00209	0.00621	CbGbCtD
Ponatinib—CYP3A4—Indapamide—hypertension	0.00206	0.00613	CbGbCtD
Ponatinib—CYP3A4—Nisoldipine—hypertension	0.00206	0.00613	CbGbCtD
Ponatinib—CYP2D6—Clonidine—hypertension	0.00202	0.006	CbGbCtD
Ponatinib—CYP3A4—Diltiazem—hypertension	0.00199	0.00592	CbGbCtD
Ponatinib—CYP3A4—Eplerenone—hypertension	0.00199	0.00592	CbGbCtD
Ponatinib—ABCB1—Atorvastatin—hypertension	0.00191	0.00567	CbGbCtD
Ponatinib—CYP2D6—Atorvastatin—hypertension	0.0018	0.00535	CbGbCtD
Ponatinib—CYP3A4—Enalapril—hypertension	0.00177	0.00528	CbGbCtD
Ponatinib—ABCB1—Losartan—hypertension	0.00174	0.00519	CbGbCtD
Ponatinib—CYP3A4—Irbesartan—hypertension	0.00162	0.00482	CbGbCtD
Ponatinib—RET—autonomic nervous system—hypertension	0.00162	0.031	CbGeAlD
Ponatinib—CYP3A4—Amlodipine—hypertension	0.00159	0.00473	CbGbCtD
Ponatinib—ABCB1—Verapamil—hypertension	0.00154	0.00458	CbGbCtD
Ponatinib—CYP3A4—Felodipine—hypertension	0.00153	0.00456	CbGbCtD
Ponatinib—CYP3A4—Nifedipine—hypertension	0.00148	0.00441	CbGbCtD
Ponatinib—CYP3A4—Carvedilol—hypertension	0.00146	0.00434	CbGbCtD
Ponatinib—CYP3A4—Nicardipine—hypertension	0.00146	0.00434	CbGbCtD
Ponatinib—CYP2D6—Verapamil—hypertension	0.00145	0.00432	CbGbCtD
Ponatinib—CYP3A4—Propranolol—hypertension	0.00134	0.004	CbGbCtD
Ponatinib—CYP3A4—Clonidine—hypertension	0.00128	0.00381	CbGbCtD
Ponatinib—CYP3A4—Atorvastatin—hypertension	0.00114	0.0034	CbGbCtD
Ponatinib—KDR—hindlimb—hypertension	0.00111	0.0214	CbGeAlD
Ponatinib—CYP3A4—Losartan—hypertension	0.00104	0.00311	CbGbCtD
Ponatinib—CYP3A4—Verapamil—hypertension	0.000922	0.00274	CbGbCtD
Ponatinib—Nilotinib—MAPK8—hypertension	0.000863	0.311	CrCbGaD
Ponatinib—TEK—artery—hypertension	0.000835	0.016	CbGeAlD
Ponatinib—FGFR4—brainstem—hypertension	0.00083	0.0159	CbGeAlD
Ponatinib—FGFR4—nephron tubule—hypertension	0.000754	0.0145	CbGeAlD
Ponatinib—SRC—artery—hypertension	0.000742	0.0142	CbGeAlD
Ponatinib—FGFR4—heart—hypertension	0.000718	0.0138	CbGeAlD
Ponatinib—TEK—endothelium—hypertension	0.000705	0.0135	CbGeAlD
Ponatinib—KDR—artery—hypertension	0.000682	0.0131	CbGeAlD
Ponatinib—FGFR4—kidney—hypertension	0.000663	0.0127	CbGeAlD
Ponatinib—TEK—blood vessel—hypertension	0.00065	0.0125	CbGeAlD
Ponatinib—BCR—cardiac ventricle—hypertension	0.000646	0.0124	CbGeAlD
Ponatinib—FGFR4—cortex of kidney—hypertension	0.000646	0.0124	CbGeAlD
Ponatinib—SRC—endothelium—hypertension	0.000627	0.012	CbGeAlD
Ponatinib—BCR—myocardium—hypertension	0.000607	0.0117	CbGeAlD
Ponatinib—SRC—blood vessel—hypertension	0.000578	0.0111	CbGeAlD
Ponatinib—KDR—endothelium—hypertension	0.000576	0.0111	CbGeAlD
Ponatinib—FGFR1—myocardium—hypertension	0.00054	0.0104	CbGeAlD
Ponatinib—FGFR4—adrenal gland—hypertension	0.000536	0.0103	CbGeAlD
Ponatinib—KDR—blood vessel—hypertension	0.000532	0.0102	CbGeAlD
Ponatinib—KIT—endothelium—hypertension	0.000511	0.0098	CbGeAlD
Ponatinib—Nilotinib—PDGFRB—hypertension	0.000491	0.177	CrCbGaD
Ponatinib—FGFR3—heart—hypertension	0.00049	0.0094	CbGeAlD
Ponatinib—KIT—blood vessel—hypertension	0.000471	0.00904	CbGeAlD
Ponatinib—TEK—cardiac ventricle—hypertension	0.000468	0.00898	CbGeAlD
Ponatinib—FGFR4—endocrine gland—hypertension	0.000465	0.00891	CbGeAlD
Ponatinib—FGFR3—kidney—hypertension	0.000452	0.00868	CbGeAlD
Ponatinib—BCR—nephron tubule—hypertension	0.000445	0.00854	CbGeAlD
Ponatinib—FGFR3—cortex of kidney—hypertension	0.000441	0.00845	CbGeAlD
Ponatinib—TEK—myocardium—hypertension	0.000441	0.00845	CbGeAlD
Ponatinib—BCR—adrenal cortex—hypertension	0.000438	0.00841	CbGeAlD
Ponatinib—BCR—heart—hypertension	0.000424	0.00813	CbGeAlD
Ponatinib—FLT3—heart—hypertension	0.000421	0.00807	CbGeAlD
Ponatinib—FGFR4—central nervous system—hypertension	0.000419	0.00803	CbGeAlD
Ponatinib—BCR—decidua—hypertension	0.000412	0.00791	CbGeAlD
Ponatinib—Imatinib—PDGFRB—hypertension	0.00041	0.147	CrCbGaD
Ponatinib—FLT3—cardiovascular system—hypertension	0.000397	0.00762	CbGeAlD
Ponatinib—FGFR3—medulla oblongata—hypertension	0.000395	0.00758	CbGeAlD
Ponatinib—KDR—cardiac ventricle—hypertension	0.000383	0.00734	CbGeAlD
Ponatinib—BCR—cortex of kidney—hypertension	0.000381	0.00731	CbGeAlD
Ponatinib—FGFR1—heart—hypertension	0.000377	0.00723	CbGeAlD
Ponatinib—FGFR2—brainstem—hypertension	0.000371	0.00711	CbGeAlD
Ponatinib—FGFR1—decidua—hypertension	0.000367	0.00704	CbGeAlD
Ponatinib—FGFR3—adrenal gland—hypertension	0.000366	0.00701	CbGeAlD
Ponatinib—BCR—cardiac atrium—hypertension	0.000363	0.00695	CbGeAlD
Ponatinib—KDR—myocardium—hypertension	0.00036	0.00691	CbGeAlD
Ponatinib—BCR—medulla oblongata—hypertension	0.000342	0.00656	CbGeAlD
Ponatinib—FGFR1—cortex of kidney—hypertension	0.000339	0.00651	CbGeAlD
Ponatinib—Nilotinib—CA9—hypertension	0.000338	0.121	CrCbGaD
Ponatinib—LCK—heart—hypertension	0.000338	0.00647	CbGeAlD
Ponatinib—RET—heart—hypertension	0.000338	0.00647	CbGeAlD
Ponatinib—CYP3A4—urine—hypertension	0.000332	0.00638	CbGeAlD
Ponatinib—LCK—decidua—hypertension	0.000328	0.0063	CbGeAlD
Ponatinib—RET—decidua—hypertension	0.000328	0.0063	CbGeAlD
Ponatinib—CYP2D6—urine—hypertension	0.000327	0.00627	CbGeAlD
Ponatinib—FGFR1—cardiac atrium—hypertension	0.000323	0.00619	CbGeAlD
Ponatinib—KIT—myocardium—hypertension	0.000319	0.00612	CbGeAlD
Ponatinib—LYN—endocrine gland—hypertension	0.000319	0.00611	CbGeAlD
Ponatinib—FGFR2—smooth muscle tissue—hypertension	0.000318	0.0061	CbGeAlD
Ponatinib—TEK—adrenal cortex—hypertension	0.000318	0.0061	CbGeAlD
Ponatinib—FGFR3—endocrine gland—hypertension	0.000317	0.00608	CbGeAlD
Ponatinib—BCR—adrenal gland—hypertension	0.000316	0.00607	CbGeAlD
Ponatinib—FLT3—adrenal gland—hypertension	0.000314	0.00603	CbGeAlD
Ponatinib—RET—kidney—hypertension	0.000312	0.00598	CbGeAlD
Ponatinib—TEK—heart—hypertension	0.000308	0.0059	CbGeAlD
Ponatinib—TEK—smooth muscle tissue—hypertension	0.000305	0.00585	CbGeAlD
Ponatinib—FGFR1—medulla oblongata—hypertension	0.000304	0.00583	CbGeAlD
Ponatinib—FGFR2—cardiovascular system—hypertension	0.000303	0.0058	CbGeAlD
Ponatinib—TEK—decidua—hypertension	0.000299	0.00574	CbGeAlD
Ponatinib—FGFR2—kidney—hypertension	0.000296	0.00568	CbGeAlD
Ponatinib—ABL1—cardiac ventricle—hypertension	0.000295	0.00566	CbGeAlD
Ponatinib—TEK—cardiovascular system—hypertension	0.00029	0.00557	CbGeAlD
Ponatinib—LYN—central nervous system—hypertension	0.000287	0.00551	CbGeAlD
Ponatinib—FGFR3—central nervous system—hypertension	0.000286	0.00548	CbGeAlD
Ponatinib—TEK—kidney—hypertension	0.000284	0.00545	CbGeAlD
Ponatinib—Imatinib—CA9—hypertension	0.000282	0.101	CrCbGaD
Ponatinib—FGFR1—adrenal gland—hypertension	0.000282	0.0054	CbGeAlD
Ponatinib—PDGFRA—heart—hypertension	0.000279	0.00534	CbGeAlD
Ponatinib—ABL1—myocardium—hypertension	0.000278	0.00533	CbGeAlD
Ponatinib—TEK—cortex of kidney—hypertension	0.000276	0.0053	CbGeAlD
Ponatinib—PDGFRA—smooth muscle tissue—hypertension	0.000276	0.0053	CbGeAlD
Ponatinib—BCR—endocrine gland—hypertension	0.000274	0.00526	CbGeAlD
Ponatinib—SRC—heart—hypertension	0.000273	0.00524	CbGeAlD
Ponatinib—FLT3—endocrine gland—hypertension	0.000272	0.00523	CbGeAlD
Ponatinib—RET—medulla oblongata—hypertension	0.000272	0.00522	CbGeAlD
Ponatinib—SRC—smooth muscle tissue—hypertension	0.000271	0.0052	CbGeAlD
Ponatinib—PDGFRA—decidua—hypertension	0.000271	0.0052	CbGeAlD
Ponatinib—SRC—decidua—hypertension	0.000266	0.0051	CbGeAlD
Ponatinib—KDR—nephron tubule—hypertension	0.000264	0.00506	CbGeAlD
Ponatinib—TEK—cardiac atrium—hypertension	0.000263	0.00504	CbGeAlD
Ponatinib—PDGFRA—cardiovascular system—hypertension	0.000263	0.00504	CbGeAlD
Ponatinib—KDR—adrenal cortex—hypertension	0.00026	0.00498	CbGeAlD
Ponatinib—SRC—cardiovascular system—hypertension	0.000258	0.00494	CbGeAlD
Ponatinib—KIT—brainstem—hypertension	0.000258	0.00494	CbGeAlD
Ponatinib—SRC—kidney—hypertension	0.000252	0.00484	CbGeAlD
Ponatinib—LCK—adrenal gland—hypertension	0.000252	0.00483	CbGeAlD
Ponatinib—RET—adrenal gland—hypertension	0.000252	0.00483	CbGeAlD
Ponatinib—KDR—heart—hypertension	0.000251	0.00482	CbGeAlD
Ponatinib—KDR—smooth muscle tissue—hypertension	0.000249	0.00478	CbGeAlD
Ponatinib—TEK—medulla oblongata—hypertension	0.000248	0.00476	CbGeAlD
Ponatinib—BCR—central nervous system—hypertension	0.000247	0.00474	CbGeAlD
Ponatinib—KDR—decidua—hypertension	0.000244	0.00469	CbGeAlD
Ponatinib—FGFR2—adrenal gland—hypertension	0.000239	0.00459	CbGeAlD
Ponatinib—KDR—cardiovascular system—hypertension	0.000237	0.00455	CbGeAlD
Ponatinib—KIT—nephron tubule—hypertension	0.000234	0.00449	CbGeAlD
Ponatinib—SRC—cardiac atrium—hypertension	0.000234	0.00448	CbGeAlD
Ponatinib—KDR—kidney—hypertension	0.000232	0.00445	CbGeAlD
Ponatinib—TEK—adrenal gland—hypertension	0.00023	0.0044	CbGeAlD
Ponatinib—KDR—cortex of kidney—hypertension	0.000226	0.00433	CbGeAlD
Ponatinib—ABL1—brainstem—hypertension	0.000224	0.0043	CbGeAlD
Ponatinib—KIT—heart—hypertension	0.000223	0.00427	CbGeAlD
Ponatinib—KIT—smooth muscle tissue—hypertension	0.000221	0.00424	CbGeAlD
Ponatinib—RET—endocrine gland—hypertension	0.000218	0.00419	CbGeAlD
Ponatinib—KIT—decidua—hypertension	0.000217	0.00415	CbGeAlD
Ponatinib—KDR—cardiac atrium—hypertension	0.000215	0.00412	CbGeAlD
Ponatinib—ABCB11—endocrine gland—hypertension	0.000213	0.00409	CbGeAlD
Ponatinib—KIT—cardiovascular system—hypertension	0.00021	0.00403	CbGeAlD
Ponatinib—PDGFRA—adrenal gland—hypertension	0.000208	0.00399	CbGeAlD
Ponatinib—FGFR2—endocrine gland—hypertension	0.000208	0.00398	CbGeAlD
Ponatinib—KIT—kidney—hypertension	0.000206	0.00394	CbGeAlD
Ponatinib—SRC—adrenal gland—hypertension	0.000204	0.00391	CbGeAlD
Ponatinib—ABL1—nephron tubule—hypertension	0.000204	0.00391	CbGeAlD
Ponatinib—KDR—medulla oblongata—hypertension	0.000203	0.00389	CbGeAlD
Ponatinib—ABL1—adrenal cortex—hypertension	0.0002	0.00384	CbGeAlD
Ponatinib—KIT—cortex of kidney—hypertension	0.0002	0.00384	CbGeAlD
Ponatinib—TEK—endocrine gland—hypertension	0.000199	0.00382	CbGeAlD
Ponatinib—RET—central nervous system—hypertension	0.000197	0.00378	CbGeAlD
Ponatinib—ABL1—heart—hypertension	0.000194	0.00372	CbGeAlD
Ponatinib—ABL1—smooth muscle tissue—hypertension	0.000192	0.00369	CbGeAlD
Ponatinib—ABL1—decidua—hypertension	0.000189	0.00362	CbGeAlD
Ponatinib—KDR—adrenal gland—hypertension	0.000188	0.0036	CbGeAlD
Ponatinib—Imatinib—CYP3A5—hypertension	0.000187	0.0674	CrCbGaD
Ponatinib—FGFR2—central nervous system—hypertension	0.000187	0.00359	CbGeAlD
Ponatinib—ABL1—cardiovascular system—hypertension	0.000183	0.00351	CbGeAlD
Ponatinib—PDGFRA—endocrine gland—hypertension	0.00018	0.00346	CbGeAlD
Ponatinib—KIT—medulla oblongata—hypertension	0.00018	0.00344	CbGeAlD
Ponatinib—TEK—central nervous system—hypertension	0.000179	0.00344	CbGeAlD
Ponatinib—ABL1—kidney—hypertension	0.000179	0.00343	CbGeAlD
Ponatinib—SRC—endocrine gland—hypertension	0.000177	0.00339	CbGeAlD
Ponatinib—ABL1—cortex of kidney—hypertension	0.000174	0.00334	CbGeAlD
Ponatinib—KIT—adrenal gland—hypertension	0.000166	0.00319	CbGeAlD
Ponatinib—ABL1—cardiac atrium—hypertension	0.000166	0.00318	CbGeAlD
Ponatinib—KDR—endocrine gland—hypertension	0.000163	0.00312	CbGeAlD
Ponatinib—PDGFRA—central nervous system—hypertension	0.000162	0.00312	CbGeAlD
Ponatinib—SRC—central nervous system—hypertension	0.000159	0.00306	CbGeAlD
Ponatinib—ABL1—medulla oblongata—hypertension	0.000156	0.003	CbGeAlD
Ponatinib—KDR—central nervous system—hypertension	0.000147	0.00281	CbGeAlD
Ponatinib—ABL1—adrenal gland—hypertension	0.000145	0.00278	CbGeAlD
Ponatinib—KIT—endocrine gland—hypertension	0.000144	0.00276	CbGeAlD
Ponatinib—Imatinib—PTGS1—hypertension	0.000139	0.05	CrCbGaD
Ponatinib—KIT—central nervous system—hypertension	0.00013	0.00249	CbGeAlD
Ponatinib—ABCG2—nephron tubule—hypertension	0.000128	0.00246	CbGeAlD
Ponatinib—ABCB1—blood vessel—hypertension	0.000128	0.00245	CbGeAlD
Ponatinib—ABCG2—adrenal cortex—hypertension	0.000126	0.00242	CbGeAlD
Ponatinib—ABL1—endocrine gland—hypertension	0.000125	0.00241	CbGeAlD
Ponatinib—ABCG2—heart—hypertension	0.000122	0.00234	CbGeAlD
Ponatinib—CYP3A5—nephron tubule—hypertension	0.000119	0.00229	CbGeAlD
Ponatinib—ABCG2—decidua—hypertension	0.000119	0.00228	CbGeAlD
Ponatinib—CYP2C8—kidney—hypertension	0.000116	0.00223	CbGeAlD
Ponatinib—ABL1—central nervous system—hypertension	0.000113	0.00217	CbGeAlD
Ponatinib—CYP3A5—kidney—hypertension	0.000105	0.00201	CbGeAlD
Ponatinib—CYP3A5—cortex of kidney—hypertension	0.000102	0.00196	CbGeAlD
Ponatinib—ABCG2—medulla oblongata—hypertension	9.86e-05	0.00189	CbGeAlD
Ponatinib—CYP2D6—brainstem—hypertension	9.69e-05	0.00186	CbGeAlD
Ponatinib—ABCG2—adrenal gland—hypertension	9.13e-05	0.00175	CbGeAlD
Ponatinib—CYP2C8—endocrine gland—hypertension	8.14e-05	0.00156	CbGeAlD
Ponatinib—CYP3A4—kidney—hypertension	7.86e-05	0.00151	CbGeAlD
Ponatinib—CYP2D6—kidney—hypertension	7.74e-05	0.00148	CbGeAlD
Ponatinib—CYP3A5—endocrine gland—hypertension	7.35e-05	0.00141	CbGeAlD
Ponatinib—Imatinib—ALB—hypertension	7.08e-05	0.0255	CrCbGaD
Ponatinib—ABCB1—nephron tubule—hypertension	6.33e-05	0.00121	CbGeAlD
Ponatinib—ABCB1—adrenal cortex—hypertension	6.23e-05	0.0012	CbGeAlD
Ponatinib—ABCB1—heart—hypertension	6.03e-05	0.00116	CbGeAlD
Ponatinib—ABCB1—decidua—hypertension	5.86e-05	0.00112	CbGeAlD
Ponatinib—ABCB1—cardiovascular system—hypertension	5.69e-05	0.00109	CbGeAlD
Ponatinib—ABCB1—kidney—hypertension	5.57e-05	0.00107	CbGeAlD
Ponatinib—CYP3A4—endocrine gland—hypertension	5.51e-05	0.00106	CbGeAlD
Ponatinib—CYP2D6—endocrine gland—hypertension	5.42e-05	0.00104	CbGeAlD
Ponatinib—ABCB1—cortex of kidney—hypertension	5.42e-05	0.00104	CbGeAlD
Ponatinib—CYP3A4—central nervous system—hypertension	4.97e-05	0.000953	CbGeAlD
Ponatinib—CYP2D6—central nervous system—hypertension	4.89e-05	0.000938	CbGeAlD
Ponatinib—ABCB1—medulla oblongata—hypertension	4.86e-05	0.000932	CbGeAlD
Ponatinib—ABCB1—adrenal gland—hypertension	4.5e-05	0.000863	CbGeAlD
Ponatinib—ABCB1—endocrine gland—hypertension	3.9e-05	0.000748	CbGeAlD
Ponatinib—ABCB1—central nervous system—hypertension	3.52e-05	0.000674	CbGeAlD
Ponatinib—Decreased appetite—Losartan—hypertension	1.77e-05	0.000123	CcSEcCtD
Ponatinib—Gastrointestinal pain—Irbesartan—hypertension	1.77e-05	0.000123	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	1.76e-05	0.000123	CcSEcCtD
Ponatinib—Body temperature increased—Captopril—hypertension	1.76e-05	0.000123	CcSEcCtD
Ponatinib—Abdominal pain—Captopril—hypertension	1.76e-05	0.000123	CcSEcCtD
Ponatinib—Headache—Carvedilol—hypertension	1.76e-05	0.000123	CcSEcCtD
Ponatinib—Rash—Doxazosin—hypertension	1.75e-05	0.000122	CcSEcCtD
Ponatinib—Fatigue—Losartan—hypertension	1.75e-05	0.000122	CcSEcCtD
Ponatinib—Dermatitis—Doxazosin—hypertension	1.75e-05	0.000122	CcSEcCtD
Ponatinib—Gastrointestinal pain—Hydrochlorothiazide—hypertension	1.75e-05	0.000122	CcSEcCtD
Ponatinib—Vomiting—Fosinopril—hypertension	1.75e-05	0.000122	CcSEcCtD
Ponatinib—Nausea—Propranolol—hypertension	1.74e-05	0.000121	CcSEcCtD
Ponatinib—Oedema—Ramipril—hypertension	1.74e-05	0.000121	CcSEcCtD
Ponatinib—Headache—Doxazosin—hypertension	1.74e-05	0.000121	CcSEcCtD
Ponatinib—Dry mouth—Timolol—hypertension	1.74e-05	0.000121	CcSEcCtD
Ponatinib—Pain—Losartan—hypertension	1.74e-05	0.000121	CcSEcCtD
Ponatinib—Constipation—Losartan—hypertension	1.74e-05	0.000121	CcSEcCtD
Ponatinib—Vomiting—Eplerenone—hypertension	1.74e-05	0.000121	CcSEcCtD
Ponatinib—Leukopenia—Lisinopril—hypertension	1.73e-05	0.000121	CcSEcCtD
Ponatinib—Rash—Fosinopril—hypertension	1.73e-05	0.000121	CcSEcCtD
Ponatinib—Dermatitis—Fosinopril—hypertension	1.73e-05	0.000121	CcSEcCtD
Ponatinib—Vomiting—Nifedipine—hypertension	1.72e-05	0.00012	CcSEcCtD
Ponatinib—Gastrointestinal pain—Furosemide—hypertension	1.72e-05	0.00012	CcSEcCtD
Ponatinib—Rash—Eplerenone—hypertension	1.72e-05	0.00012	CcSEcCtD
Ponatinib—Headache—Fosinopril—hypertension	1.72e-05	0.00012	CcSEcCtD
Ponatinib—Dermatitis—Eplerenone—hypertension	1.72e-05	0.00012	CcSEcCtD
Ponatinib—Diarrhoea—Valsartan—hypertension	1.72e-05	0.00012	CcSEcCtD
Ponatinib—Asthenia—Clonidine—hypertension	1.72e-05	0.00012	CcSEcCtD
Ponatinib—Vomiting—Verapamil—hypertension	1.72e-05	0.000119	CcSEcCtD
Ponatinib—Abdominal pain—Perindopril—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Body temperature increased—Perindopril—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Diarrhoea—Olmesartan—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Headache—Eplerenone—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Rash—Nifedipine—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Nervous system disorder—Ramipril—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Dermatitis—Nifedipine—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Abdominal pain—Irbesartan—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Body temperature increased—Irbesartan—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Thrombocytopenia—Ramipril—hypertension	1.71e-05	0.000119	CcSEcCtD
Ponatinib—Oedema—Timolol—hypertension	1.7e-05	0.000119	CcSEcCtD
Ponatinib—Rash—Verapamil—hypertension	1.7e-05	0.000118	CcSEcCtD
Ponatinib—Dermatitis—Verapamil—hypertension	1.7e-05	0.000118	CcSEcCtD
Ponatinib—Headache—Nifedipine—hypertension	1.7e-05	0.000118	CcSEcCtD
Ponatinib—Pruritus—Clonidine—hypertension	1.69e-05	0.000118	CcSEcCtD
Ponatinib—Abdominal pain—Hydrochlorothiazide—hypertension	1.69e-05	0.000118	CcSEcCtD
Ponatinib—Body temperature increased—Hydrochlorothiazide—hypertension	1.69e-05	0.000118	CcSEcCtD
Ponatinib—Skin disorder—Ramipril—hypertension	1.69e-05	0.000118	CcSEcCtD
Ponatinib—Infection—Timolol—hypertension	1.69e-05	0.000118	CcSEcCtD
Ponatinib—Headache—Verapamil—hypertension	1.69e-05	0.000118	CcSEcCtD
Ponatinib—Cough—Lisinopril—hypertension	1.69e-05	0.000118	CcSEcCtD
Ponatinib—Nausea—Diltiazem—hypertension	1.69e-05	0.000117	CcSEcCtD
Ponatinib—Nausea—Indapamide—hypertension	1.69e-05	0.000117	CcSEcCtD
Ponatinib—Hyperhidrosis—Ramipril—hypertension	1.68e-05	0.000117	CcSEcCtD
Ponatinib—Asthenia—Trandolapril—hypertension	1.68e-05	0.000117	CcSEcCtD
Ponatinib—Nervous system disorder—Timolol—hypertension	1.67e-05	0.000116	CcSEcCtD
Ponatinib—Nausea—Carvedilol—hypertension	1.67e-05	0.000116	CcSEcCtD
Ponatinib—Asthenia—Enalapril—hypertension	1.67e-05	0.000116	CcSEcCtD
Ponatinib—Abdominal pain—Furosemide—hypertension	1.66e-05	0.000116	CcSEcCtD
Ponatinib—Body temperature increased—Furosemide—hypertension	1.66e-05	0.000116	CcSEcCtD
Ponatinib—Gastrointestinal pain—Losartan—hypertension	1.66e-05	0.000116	CcSEcCtD
Ponatinib—Dizziness—Valsartan—hypertension	1.66e-05	0.000116	CcSEcCtD
Ponatinib—Skin disorder—Timolol—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Dizziness—Olmesartan—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Pruritus—Trandolapril—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Nausea—Doxazosin—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Myalgia—Lisinopril—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Arthralgia—Lisinopril—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Body temperature increased—Betaxolol—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Hyperhidrosis—Timolol—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Asthenia—Telmisartan—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Pruritus—Enalapril—hypertension	1.65e-05	0.000115	CcSEcCtD
Ponatinib—Diarrhoea—Clonidine—hypertension	1.64e-05	0.000114	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.64e-05	0.000114	CcSEcCtD
Ponatinib—Nausea—Fosinopril—hypertension	1.63e-05	0.000114	CcSEcCtD
Ponatinib—Pruritus—Telmisartan—hypertension	1.62e-05	0.000113	CcSEcCtD
Ponatinib—Nausea—Eplerenone—hypertension	1.62e-05	0.000113	CcSEcCtD
Ponatinib—Dry mouth—Lisinopril—hypertension	1.61e-05	0.000112	CcSEcCtD
Ponatinib—Nausea—Nifedipine—hypertension	1.61e-05	0.000112	CcSEcCtD
Ponatinib—Abdominal pain—Losartan—hypertension	1.61e-05	0.000112	CcSEcCtD
Ponatinib—Body temperature increased—Losartan—hypertension	1.61e-05	0.000112	CcSEcCtD
Ponatinib—Nausea—Verapamil—hypertension	1.6e-05	0.000112	CcSEcCtD
Ponatinib—Asthenia—Captopril—hypertension	1.6e-05	0.000111	CcSEcCtD
Ponatinib—Diarrhoea—Trandolapril—hypertension	1.6e-05	0.000111	CcSEcCtD
Ponatinib—Vomiting—Valsartan—hypertension	1.6e-05	0.000111	CcSEcCtD
Ponatinib—Diarrhoea—Enalapril—hypertension	1.59e-05	0.000111	CcSEcCtD
Ponatinib—Vomiting—Olmesartan—hypertension	1.59e-05	0.000111	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Ramipril—hypertension	1.59e-05	0.000111	CcSEcCtD
Ponatinib—Rash—Valsartan—hypertension	1.58e-05	0.00011	CcSEcCtD
Ponatinib—Dizziness—Clonidine—hypertension	1.58e-05	0.00011	CcSEcCtD
Ponatinib—Dermatitis—Valsartan—hypertension	1.58e-05	0.00011	CcSEcCtD
Ponatinib—Oedema—Lisinopril—hypertension	1.58e-05	0.00011	CcSEcCtD
Ponatinib—Pruritus—Captopril—hypertension	1.58e-05	0.00011	CcSEcCtD
Ponatinib—Rash—Olmesartan—hypertension	1.58e-05	0.00011	CcSEcCtD
Ponatinib—Insomnia—Ramipril—hypertension	1.58e-05	0.00011	CcSEcCtD
Ponatinib—Dermatitis—Olmesartan—hypertension	1.57e-05	0.00011	CcSEcCtD
Ponatinib—Headache—Valsartan—hypertension	1.57e-05	0.00011	CcSEcCtD
Ponatinib—Diarrhoea—Telmisartan—hypertension	1.57e-05	0.000109	CcSEcCtD
Ponatinib—Infection—Lisinopril—hypertension	1.57e-05	0.000109	CcSEcCtD
Ponatinib—Headache—Olmesartan—hypertension	1.57e-05	0.000109	CcSEcCtD
Ponatinib—Paraesthesia—Ramipril—hypertension	1.56e-05	0.000109	CcSEcCtD
Ponatinib—Asthenia—Perindopril—hypertension	1.55e-05	0.000108	CcSEcCtD
Ponatinib—Dyspnoea—Ramipril—hypertension	1.55e-05	0.000108	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Timolol—hypertension	1.55e-05	0.000108	CcSEcCtD
Ponatinib—Asthenia—Irbesartan—hypertension	1.55e-05	0.000108	CcSEcCtD
Ponatinib—Thrombocytopenia—Lisinopril—hypertension	1.55e-05	0.000108	CcSEcCtD
Ponatinib—Dizziness—Trandolapril—hypertension	1.54e-05	0.000108	CcSEcCtD
Ponatinib—Insomnia—Timolol—hypertension	1.54e-05	0.000107	CcSEcCtD
Ponatinib—Dizziness—Enalapril—hypertension	1.54e-05	0.000107	CcSEcCtD
Ponatinib—Asthenia—Hydrochlorothiazide—hypertension	1.54e-05	0.000107	CcSEcCtD
Ponatinib—Skin disorder—Lisinopril—hypertension	1.53e-05	0.000107	CcSEcCtD
Ponatinib—Dyspepsia—Ramipril—hypertension	1.53e-05	0.000107	CcSEcCtD
Ponatinib—Pruritus—Perindopril—hypertension	1.53e-05	0.000107	CcSEcCtD
Ponatinib—Paraesthesia—Timolol—hypertension	1.53e-05	0.000107	CcSEcCtD
Ponatinib—Pruritus—Irbesartan—hypertension	1.53e-05	0.000106	CcSEcCtD
Ponatinib—Hyperhidrosis—Lisinopril—hypertension	1.53e-05	0.000106	CcSEcCtD
Ponatinib—Diarrhoea—Captopril—hypertension	1.53e-05	0.000106	CcSEcCtD
Ponatinib—Vomiting—Clonidine—hypertension	1.52e-05	0.000106	CcSEcCtD
Ponatinib—Dyspnoea—Timolol—hypertension	1.52e-05	0.000106	CcSEcCtD
Ponatinib—Dizziness—Telmisartan—hypertension	1.52e-05	0.000106	CcSEcCtD
Ponatinib—Pruritus—Hydrochlorothiazide—hypertension	1.51e-05	0.000106	CcSEcCtD
Ponatinib—Decreased appetite—Ramipril—hypertension	1.51e-05	0.000105	CcSEcCtD
Ponatinib—Asthenia—Furosemide—hypertension	1.51e-05	0.000105	CcSEcCtD
Ponatinib—Rash—Clonidine—hypertension	1.51e-05	0.000105	CcSEcCtD
Ponatinib—Dermatitis—Clonidine—hypertension	1.51e-05	0.000105	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Ramipril—hypertension	1.5e-05	0.000105	CcSEcCtD
Ponatinib—Fatigue—Ramipril—hypertension	1.5e-05	0.000105	CcSEcCtD
Ponatinib—Headache—Clonidine—hypertension	1.5e-05	0.000104	CcSEcCtD
Ponatinib—Dyspepsia—Timolol—hypertension	1.5e-05	0.000104	CcSEcCtD
Ponatinib—Asthenia—Betaxolol—hypertension	1.5e-05	0.000104	CcSEcCtD
Ponatinib—Nausea—Valsartan—hypertension	1.49e-05	0.000104	CcSEcCtD
Ponatinib—Pruritus—Furosemide—hypertension	1.49e-05	0.000104	CcSEcCtD
Ponatinib—Constipation—Ramipril—hypertension	1.49e-05	0.000104	CcSEcCtD
Ponatinib—Nausea—Olmesartan—hypertension	1.48e-05	0.000103	CcSEcCtD
Ponatinib—Vomiting—Trandolapril—hypertension	1.48e-05	0.000103	CcSEcCtD
Ponatinib—Diarrhoea—Perindopril—hypertension	1.48e-05	0.000103	CcSEcCtD
Ponatinib—Decreased appetite—Timolol—hypertension	1.48e-05	0.000103	CcSEcCtD
Ponatinib—Vomiting—Enalapril—hypertension	1.48e-05	0.000103	CcSEcCtD
Ponatinib—Diarrhoea—Irbesartan—hypertension	1.48e-05	0.000103	CcSEcCtD
Ponatinib—Dizziness—Captopril—hypertension	1.48e-05	0.000103	CcSEcCtD
Ponatinib—Pruritus—Betaxolol—hypertension	1.47e-05	0.000103	CcSEcCtD
Ponatinib—Rash—Trandolapril—hypertension	1.47e-05	0.000103	CcSEcCtD
Ponatinib—Dermatitis—Trandolapril—hypertension	1.47e-05	0.000102	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Timolol—hypertension	1.47e-05	0.000102	CcSEcCtD
Ponatinib—Fatigue—Timolol—hypertension	1.47e-05	0.000102	CcSEcCtD
Ponatinib—Rash—Enalapril—hypertension	1.47e-05	0.000102	CcSEcCtD
Ponatinib—Dermatitis—Enalapril—hypertension	1.46e-05	0.000102	CcSEcCtD
Ponatinib—Diarrhoea—Hydrochlorothiazide—hypertension	1.46e-05	0.000102	CcSEcCtD
Ponatinib—Headache—Trandolapril—hypertension	1.46e-05	0.000102	CcSEcCtD
Ponatinib—Vomiting—Telmisartan—hypertension	1.46e-05	0.000102	CcSEcCtD
Ponatinib—Asthenia—Losartan—hypertension	1.46e-05	0.000102	CcSEcCtD
Ponatinib—Headache—Enalapril—hypertension	1.46e-05	0.000101	CcSEcCtD
Ponatinib—Pain—Timolol—hypertension	1.46e-05	0.000101	CcSEcCtD
Ponatinib—Rash—Telmisartan—hypertension	1.45e-05	0.000101	CcSEcCtD
Ponatinib—Dermatitis—Telmisartan—hypertension	1.44e-05	0.000101	CcSEcCtD
Ponatinib—Diarrhoea—Furosemide—hypertension	1.44e-05	0.0001	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Lisinopril—hypertension	1.44e-05	0.0001	CcSEcCtD
Ponatinib—Pruritus—Losartan—hypertension	1.44e-05	0.0001	CcSEcCtD
Ponatinib—Headache—Telmisartan—hypertension	1.44e-05	0.0001	CcSEcCtD
Ponatinib—Dizziness—Perindopril—hypertension	1.43e-05	9.98e-05	CcSEcCtD
Ponatinib—Insomnia—Lisinopril—hypertension	1.43e-05	9.95e-05	CcSEcCtD
Ponatinib—Dizziness—Irbesartan—hypertension	1.43e-05	9.94e-05	CcSEcCtD
Ponatinib—Diarrhoea—Betaxolol—hypertension	1.43e-05	9.93e-05	CcSEcCtD
Ponatinib—Gastrointestinal pain—Ramipril—hypertension	1.42e-05	9.92e-05	CcSEcCtD
Ponatinib—Nausea—Clonidine—hypertension	1.42e-05	9.91e-05	CcSEcCtD
Ponatinib—Paraesthesia—Lisinopril—hypertension	1.42e-05	9.88e-05	CcSEcCtD
Ponatinib—Vomiting—Captopril—hypertension	1.42e-05	9.88e-05	CcSEcCtD
Ponatinib—Dizziness—Hydrochlorothiazide—hypertension	1.42e-05	9.86e-05	CcSEcCtD
Ponatinib—Dyspnoea—Lisinopril—hypertension	1.41e-05	9.81e-05	CcSEcCtD
Ponatinib—Rash—Captopril—hypertension	1.41e-05	9.8e-05	CcSEcCtD
Ponatinib—Dermatitis—Captopril—hypertension	1.41e-05	9.79e-05	CcSEcCtD
Ponatinib—Headache—Captopril—hypertension	1.4e-05	9.73e-05	CcSEcCtD
Ponatinib—Gastrointestinal pain—Timolol—hypertension	1.39e-05	9.7e-05	CcSEcCtD
Ponatinib—Dizziness—Furosemide—hypertension	1.39e-05	9.7e-05	CcSEcCtD
Ponatinib—Dyspepsia—Lisinopril—hypertension	1.39e-05	9.69e-05	CcSEcCtD
Ponatinib—Diarrhoea—Losartan—hypertension	1.39e-05	9.68e-05	CcSEcCtD
Ponatinib—Nausea—Trandolapril—hypertension	1.39e-05	9.66e-05	CcSEcCtD
Ponatinib—Nausea—Enalapril—hypertension	1.38e-05	9.62e-05	CcSEcCtD
Ponatinib—Dizziness—Betaxolol—hypertension	1.38e-05	9.6e-05	CcSEcCtD
Ponatinib—Vomiting—Perindopril—hypertension	1.38e-05	9.59e-05	CcSEcCtD
Ponatinib—Abdominal pain—Ramipril—hypertension	1.38e-05	9.59e-05	CcSEcCtD
Ponatinib—Body temperature increased—Ramipril—hypertension	1.38e-05	9.59e-05	CcSEcCtD
Ponatinib—Decreased appetite—Lisinopril—hypertension	1.37e-05	9.57e-05	CcSEcCtD
Ponatinib—Vomiting—Irbesartan—hypertension	1.37e-05	9.56e-05	CcSEcCtD
Ponatinib—Rash—Perindopril—hypertension	1.37e-05	9.51e-05	CcSEcCtD
Ponatinib—Dermatitis—Perindopril—hypertension	1.36e-05	9.5e-05	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Lisinopril—hypertension	1.36e-05	9.5e-05	CcSEcCtD
Ponatinib—Nausea—Telmisartan—hypertension	1.36e-05	9.49e-05	CcSEcCtD
Ponatinib—Fatigue—Lisinopril—hypertension	1.36e-05	9.49e-05	CcSEcCtD
Ponatinib—Vomiting—Hydrochlorothiazide—hypertension	1.36e-05	9.48e-05	CcSEcCtD
Ponatinib—Rash—Irbesartan—hypertension	1.36e-05	9.48e-05	CcSEcCtD
Ponatinib—Dermatitis—Irbesartan—hypertension	1.36e-05	9.47e-05	CcSEcCtD
Ponatinib—Headache—Perindopril—hypertension	1.36e-05	9.45e-05	CcSEcCtD
Ponatinib—Headache—Irbesartan—hypertension	1.35e-05	9.42e-05	CcSEcCtD
Ponatinib—Pain—Lisinopril—hypertension	1.35e-05	9.41e-05	CcSEcCtD
Ponatinib—Constipation—Lisinopril—hypertension	1.35e-05	9.41e-05	CcSEcCtD
Ponatinib—Rash—Hydrochlorothiazide—hypertension	1.35e-05	9.4e-05	CcSEcCtD
Ponatinib—Dermatitis—Hydrochlorothiazide—hypertension	1.35e-05	9.39e-05	CcSEcCtD
Ponatinib—Abdominal pain—Timolol—hypertension	1.35e-05	9.38e-05	CcSEcCtD
Ponatinib—Body temperature increased—Timolol—hypertension	1.35e-05	9.38e-05	CcSEcCtD
Ponatinib—Dizziness—Losartan—hypertension	1.34e-05	9.36e-05	CcSEcCtD
Ponatinib—Headache—Hydrochlorothiazide—hypertension	1.34e-05	9.34e-05	CcSEcCtD
Ponatinib—Vomiting—Furosemide—hypertension	1.34e-05	9.32e-05	CcSEcCtD
Ponatinib—Rash—Furosemide—hypertension	1.33e-05	9.25e-05	CcSEcCtD
Ponatinib—Dermatitis—Furosemide—hypertension	1.33e-05	9.24e-05	CcSEcCtD
Ponatinib—Vomiting—Betaxolol—hypertension	1.33e-05	9.23e-05	CcSEcCtD
Ponatinib—Nausea—Captopril—hypertension	1.32e-05	9.23e-05	CcSEcCtD
Ponatinib—Headache—Furosemide—hypertension	1.32e-05	9.19e-05	CcSEcCtD
Ponatinib—Rash—Betaxolol—hypertension	1.31e-05	9.16e-05	CcSEcCtD
Ponatinib—Dermatitis—Betaxolol—hypertension	1.31e-05	9.15e-05	CcSEcCtD
Ponatinib—Headache—Betaxolol—hypertension	1.31e-05	9.1e-05	CcSEcCtD
Ponatinib—Gastrointestinal pain—Lisinopril—hypertension	1.29e-05	9e-05	CcSEcCtD
Ponatinib—Vomiting—Losartan—hypertension	1.29e-05	9e-05	CcSEcCtD
Ponatinib—Nausea—Perindopril—hypertension	1.29e-05	8.96e-05	CcSEcCtD
Ponatinib—Nausea—Irbesartan—hypertension	1.28e-05	8.93e-05	CcSEcCtD
Ponatinib—Rash—Losartan—hypertension	1.28e-05	8.92e-05	CcSEcCtD
Ponatinib—Dermatitis—Losartan—hypertension	1.28e-05	8.91e-05	CcSEcCtD
Ponatinib—Headache—Losartan—hypertension	1.27e-05	8.86e-05	CcSEcCtD
Ponatinib—Nausea—Hydrochlorothiazide—hypertension	1.27e-05	8.86e-05	CcSEcCtD
Ponatinib—Nausea—Furosemide—hypertension	1.25e-05	8.71e-05	CcSEcCtD
Ponatinib—Asthenia—Ramipril—hypertension	1.25e-05	8.71e-05	CcSEcCtD
Ponatinib—Abdominal pain—Lisinopril—hypertension	1.25e-05	8.7e-05	CcSEcCtD
Ponatinib—Body temperature increased—Lisinopril—hypertension	1.25e-05	8.7e-05	CcSEcCtD
Ponatinib—Nausea—Betaxolol—hypertension	1.24e-05	8.62e-05	CcSEcCtD
Ponatinib—Pruritus—Ramipril—hypertension	1.23e-05	8.58e-05	CcSEcCtD
Ponatinib—Asthenia—Timolol—hypertension	1.22e-05	8.51e-05	CcSEcCtD
Ponatinib—Nausea—Losartan—hypertension	1.21e-05	8.41e-05	CcSEcCtD
Ponatinib—Pruritus—Timolol—hypertension	1.2e-05	8.39e-05	CcSEcCtD
Ponatinib—Diarrhoea—Ramipril—hypertension	1.19e-05	8.3e-05	CcSEcCtD
Ponatinib—Diarrhoea—Timolol—hypertension	1.17e-05	8.12e-05	CcSEcCtD
Ponatinib—Dizziness—Ramipril—hypertension	1.15e-05	8.02e-05	CcSEcCtD
Ponatinib—Asthenia—Lisinopril—hypertension	1.13e-05	7.9e-05	CcSEcCtD
Ponatinib—Dizziness—Timolol—hypertension	1.13e-05	7.84e-05	CcSEcCtD
Ponatinib—Pruritus—Lisinopril—hypertension	1.12e-05	7.79e-05	CcSEcCtD
Ponatinib—Vomiting—Ramipril—hypertension	1.11e-05	7.71e-05	CcSEcCtD
Ponatinib—Rash—Ramipril—hypertension	1.1e-05	7.65e-05	CcSEcCtD
Ponatinib—Dermatitis—Ramipril—hypertension	1.1e-05	7.64e-05	CcSEcCtD
Ponatinib—Headache—Ramipril—hypertension	1.09e-05	7.6e-05	CcSEcCtD
Ponatinib—Vomiting—Timolol—hypertension	1.08e-05	7.54e-05	CcSEcCtD
Ponatinib—Diarrhoea—Lisinopril—hypertension	1.08e-05	7.53e-05	CcSEcCtD
Ponatinib—Rash—Timolol—hypertension	1.07e-05	7.48e-05	CcSEcCtD
Ponatinib—Dermatitis—Timolol—hypertension	1.07e-05	7.47e-05	CcSEcCtD
Ponatinib—Headache—Timolol—hypertension	1.07e-05	7.43e-05	CcSEcCtD
Ponatinib—Dizziness—Lisinopril—hypertension	1.04e-05	7.28e-05	CcSEcCtD
Ponatinib—Nausea—Ramipril—hypertension	1.03e-05	7.21e-05	CcSEcCtD
Ponatinib—Nausea—Timolol—hypertension	1.01e-05	7.05e-05	CcSEcCtD
Ponatinib—Vomiting—Lisinopril—hypertension	1e-05	7e-05	CcSEcCtD
Ponatinib—Rash—Lisinopril—hypertension	9.96e-06	6.94e-05	CcSEcCtD
Ponatinib—Dermatitis—Lisinopril—hypertension	9.95e-06	6.93e-05	CcSEcCtD
Ponatinib—Headache—Lisinopril—hypertension	9.9e-06	6.89e-05	CcSEcCtD
Ponatinib—Nausea—Lisinopril—hypertension	9.38e-06	6.54e-05	CcSEcCtD
Ponatinib—ABCB1—Metabolism—GSTM1—hypertension	5.2e-07	4.34e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—POMC—hypertension	5.2e-07	4.33e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CAT—hypertension	5.19e-07	4.33e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—FGF2—hypertension	5.19e-07	4.33e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARA—hypertension	5.18e-07	4.32e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—CDKN1A—hypertension	5.17e-07	4.31e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RHOA—hypertension	5.17e-07	4.31e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—INS—hypertension	5.17e-07	4.31e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—PTEN—hypertension	5.16e-07	4.3e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HBA1—hypertension	5.15e-07	4.3e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GNAS—hypertension	5.15e-07	4.29e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—EGFR—hypertension	5.13e-07	4.28e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP11A1—hypertension	5.12e-07	4.27e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PIK3R1—hypertension	5.12e-07	4.27e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOS3—hypertension	5.12e-07	4.27e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VEGFA—hypertension	5.11e-07	4.26e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—LPL—hypertension	5.11e-07	4.26e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VEGFA—hypertension	5.1e-07	4.25e-06	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—AKT1—hypertension	5.09e-07	4.24e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—hypertension	5.08e-07	4.24e-06	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—hypertension	5.05e-07	4.21e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MYC—hypertension	5.05e-07	4.21e-06	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—AKT1—hypertension	5.05e-07	4.21e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOB—hypertension	5.04e-07	4.2e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—hypertension	5.04e-07	4.2e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—hypertension	5.04e-07	4.2e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—AKT1—hypertension	5.03e-07	4.2e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTT1—hypertension	5.03e-07	4.19e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SLC9A1—hypertension	5.03e-07	4.19e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AGT—hypertension	5.01e-07	4.18e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—hypertension	5.01e-07	4.18e-06	CbGpPWpGaD
Ponatinib—FGFR2—Disease—AKT1—hypertension	5e-07	4.17e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADCY5—hypertension	5e-07	4.17e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IGF1—hypertension	5e-07	4.17e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AKT2—hypertension	4.99e-07	4.16e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CDKN1A—hypertension	4.99e-07	4.16e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GPX1—hypertension	4.98e-07	4.15e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PTEN—hypertension	4.98e-07	4.15e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GCLC—hypertension	4.97e-07	4.15e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CETP—hypertension	4.97e-07	4.15e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MYC—hypertension	4.96e-07	4.13e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—hypertension	4.95e-07	4.12e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARG—hypertension	4.94e-07	4.12e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—EGFR—hypertension	4.94e-07	4.12e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PRKCA—hypertension	4.93e-07	4.11e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP1A1—hypertension	4.93e-07	4.11e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CALM1—hypertension	4.93e-07	4.11e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—EP300—hypertension	4.92e-07	4.1e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOE—hypertension	4.91e-07	4.1e-06	CbGpPWpGaD
Ponatinib—KIT—Disease—AKT1—hypertension	4.91e-07	4.09e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GSTM1—hypertension	4.9e-07	4.09e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MAPK8—hypertension	4.87e-07	4.06e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—POMC—hypertension	4.87e-07	4.06e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CAV1—hypertension	4.87e-07	4.06e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOA1—hypertension	4.86e-07	4.05e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CD36—hypertension	4.85e-07	4.04e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—EGFR—hypertension	4.85e-07	4.04e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—MYC—hypertension	4.85e-07	4.04e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—INS—hypertension	4.85e-07	4.04e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—hypertension	4.83e-07	4.03e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RELA—hypertension	4.82e-07	4.02e-06	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—hypertension	4.81e-07	4.01e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—LPL—hypertension	4.81e-07	4.01e-06	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—hypertension	4.81e-07	4.01e-06	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—hypertension	4.79e-07	3.99e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP17A1—hypertension	4.76e-07	3.97e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EP300—hypertension	4.75e-07	3.96e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SERPINE1—hypertension	4.75e-07	3.96e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—EGFR—hypertension	4.74e-07	3.95e-06	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTEN—hypertension	4.73e-07	3.94e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MTOR—hypertension	4.72e-07	3.94e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS1—hypertension	4.71e-07	3.93e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ENO1—hypertension	4.71e-07	3.93e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADCY5—hypertension	4.71e-07	3.93e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MYC—hypertension	4.71e-07	3.92e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GPX1—hypertension	4.69e-07	3.91e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—hypertension	4.69e-07	3.91e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MYC—hypertension	4.69e-07	3.91e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—hypertension	4.68e-07	3.9e-06	CbGpPWpGaD
Ponatinib—FGFR1—Disease—AKT1—hypertension	4.66e-07	3.88e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—AKT1—hypertension	4.65e-07	3.87e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP1A1—hypertension	4.65e-07	3.87e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PRKCA—hypertension	4.65e-07	3.87e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SRC—hypertension	4.62e-07	3.85e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—EGFR—hypertension	4.6e-07	3.84e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MTHFR—hypertension	4.6e-07	3.83e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—FGF2—hypertension	4.59e-07	3.83e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—EGFR—hypertension	4.59e-07	3.83e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RHOA—hypertension	4.58e-07	3.82e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CD36—hypertension	4.57e-07	3.81e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—EGFR—hypertension	4.54e-07	3.79e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL8—hypertension	4.54e-07	3.79e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CTGF—hypertension	4.54e-07	3.78e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOS3—hypertension	4.53e-07	3.78e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PIK3R1—hypertension	4.53e-07	3.78e-06	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—EP300—hypertension	4.51e-07	3.76e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARA—hypertension	4.51e-07	3.76e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VEGFA—hypertension	4.5e-07	3.75e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT2—hypertension	4.5e-07	3.75e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HMGCR—hypertension	4.5e-07	3.75e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—hypertension	4.44e-07	3.7e-06	CbGpPWpGaD
Ponatinib—LYN—Immune System—AKT1—hypertension	4.44e-07	3.7e-06	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—AKT1—hypertension	4.43e-07	3.7e-06	CbGpPWpGaD
Ponatinib—ABL1—Immune System—AKT1—hypertension	4.42e-07	3.68e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADRA2A—hypertension	4.4e-07	3.67e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AGT—hypertension	4.37e-07	3.64e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MTHFR—hypertension	4.33e-07	3.61e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CALM1—hypertension	4.29e-07	3.58e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—MYC—hypertension	4.29e-07	3.58e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOE—hypertension	4.28e-07	3.57e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—hypertension	4.28e-07	3.57e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARG—hypertension	4.28e-07	3.57e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RELA—hypertension	4.27e-07	3.56e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARA—hypertension	4.25e-07	3.54e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NOS3—hypertension	4.25e-07	3.54e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PIK3R1—hypertension	4.25e-07	3.54e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CAV1—hypertension	4.24e-07	3.54e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOA1—hypertension	4.23e-07	3.53e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—POMC—hypertension	4.22e-07	3.52e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—INS—hypertension	4.2e-07	3.5e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—EGFR—hypertension	4.2e-07	3.5e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MTOR—hypertension	4.18e-07	3.49e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TP53—hypertension	4.15e-07	3.46e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MYC—hypertension	4.14e-07	3.45e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—hypertension	4.13e-07	3.44e-06	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—AKT1—hypertension	4.12e-07	3.44e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—TH—hypertension	4.12e-07	3.44e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AGT—hypertension	4.12e-07	3.43e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—hypertension	4.11e-07	3.42e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CALM2—hypertension	4.11e-07	3.42e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CDKN1A—hypertension	4.09e-07	3.41e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PTEN—hypertension	4.08e-07	3.4e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TP53—hypertension	4.07e-07	3.39e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EGFR—hypertension	4.05e-07	3.38e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CALM1—hypertension	4.05e-07	3.37e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOE—hypertension	4.03e-07	3.36e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL8—hypertension	4.02e-07	3.35e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SLC2A4—hypertension	4.01e-07	3.34e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GCG—hypertension	4.01e-07	3.34e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CAV1—hypertension	4e-07	3.33e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MAPK8—hypertension	3.99e-07	3.33e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOA1—hypertension	3.99e-07	3.32e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—hypertension	3.94e-07	3.29e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EP300—hypertension	3.89e-07	3.25e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—hypertension	3.89e-07	3.24e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT1—hypertension	3.88e-07	3.24e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TP53—hypertension	3.86e-07	3.22e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TP53—hypertension	3.85e-07	3.21e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—hypertension	3.85e-07	3.21e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—hypertension	3.79e-07	3.16e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SRC—hypertension	3.79e-07	3.16e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—STK11—hypertension	3.77e-07	3.14e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP19A1—hypertension	3.77e-07	3.14e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARG—hypertension	3.73e-07	3.11e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—hypertension	3.73e-07	3.11e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VEGFA—hypertension	3.69e-07	3.07e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NOS3—hypertension	3.68e-07	3.07e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PIK3R1—hypertension	3.68e-07	3.07e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—POMC—hypertension	3.68e-07	3.07e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—INS—hypertension	3.66e-07	3.05e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—hypertension	3.64e-07	3.04e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—AKT1—hypertension	3.64e-07	3.03e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—hypertension	3.64e-07	3.03e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CDKN1A—hypertension	3.62e-07	3.02e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PTEN—hypertension	3.61e-07	3.01e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—hypertension	3.54e-07	2.95e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MAPK8—hypertension	3.54e-07	2.95e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—hypertension	3.53e-07	2.94e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARG—hypertension	3.51e-07	2.93e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—COMT—hypertension	3.5e-07	2.92e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—AKT1—hypertension	3.5e-07	2.92e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—hypertension	3.49e-07	2.91e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—POMC—hypertension	3.46e-07	2.89e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARGC1A—hypertension	3.46e-07	2.88e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GNB3—hypertension	3.46e-07	2.88e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EP300—hypertension	3.45e-07	2.87e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—INS—hypertension	3.45e-07	2.87e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HMOX1—hypertension	3.44e-07	2.87e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—AKT1—hypertension	3.44e-07	2.87e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TP53—hypertension	3.4e-07	2.83e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CAT—hypertension	3.39e-07	2.83e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MYC—hypertension	3.39e-07	2.83e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTEN—hypertension	3.39e-07	2.83e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—hypertension	3.38e-07	2.82e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—hypertension	3.37e-07	2.81e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GNAS—hypertension	3.36e-07	2.8e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—AKT1—hypertension	3.36e-07	2.8e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—hypertension	3.35e-07	2.79e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EGFR—hypertension	3.32e-07	2.77e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOB—hypertension	3.29e-07	2.75e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VEGFA—hypertension	3.26e-07	2.72e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—AKT1—hypertension	3.26e-07	2.72e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—AKT1—hypertension	3.25e-07	2.71e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—EP300—hypertension	3.23e-07	2.69e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—hypertension	3.22e-07	2.69e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—AKT1—hypertension	3.22e-07	2.69e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PIK3R1—hypertension	3.21e-07	2.67e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NOS3—hypertension	3.21e-07	2.67e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTM1—hypertension	3.2e-07	2.67e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—hypertension	3.16e-07	2.63e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LPL—hypertension	3.15e-07	2.62e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—hypertension	3.11e-07	2.59e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADCY5—hypertension	3.08e-07	2.57e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GPX1—hypertension	3.07e-07	2.56e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PRKCA—hypertension	3.04e-07	2.53e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP1A1—hypertension	3.04e-07	2.53e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PIK3R1—hypertension	3.02e-07	2.52e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NOS3—hypertension	3.02e-07	2.52e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MYC—hypertension	3e-07	2.5e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—hypertension	3e-07	2.5e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CD36—hypertension	2.99e-07	2.49e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—AKT1—hypertension	2.97e-07	2.48e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EGFR—hypertension	2.94e-07	2.45e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTEN—hypertension	2.94e-07	2.45e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—hypertension	2.93e-07	2.44e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—AKT1—hypertension	2.87e-07	2.39e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MTHFR—hypertension	2.83e-07	2.36e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—EP300—hypertension	2.8e-07	2.33e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TP53—hypertension	2.79e-07	2.32e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARA—hypertension	2.78e-07	2.32e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—hypertension	2.76e-07	2.3e-06	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—AKT1—hypertension	2.73e-07	2.27e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AGT—hypertension	2.69e-07	2.24e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CALM1—hypertension	2.65e-07	2.21e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOE—hypertension	2.64e-07	2.2e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CAV1—hypertension	2.61e-07	2.18e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOA1—hypertension	2.61e-07	2.17e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTEN—hypertension	2.56e-07	2.13e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—hypertension	2.55e-07	2.13e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TP53—hypertension	2.47e-07	2.06e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—EP300—hypertension	2.44e-07	2.03e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTEN—hypertension	2.41e-07	2.01e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—AKT1—hypertension	2.35e-07	1.96e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—EP300—hypertension	2.3e-07	1.92e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARG—hypertension	2.3e-07	1.91e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—POMC—hypertension	2.27e-07	1.89e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—hypertension	2.26e-07	1.88e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—INS—hypertension	2.25e-07	1.88e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AKT1—hypertension	2.08e-07	1.74e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—hypertension	2.07e-07	1.72e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PIK3R1—hypertension	1.98e-07	1.65e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NOS3—hypertension	1.98e-07	1.65e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—AKT1—hypertension	1.95e-07	1.63e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—hypertension	1.81e-07	1.51e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AKT1—hypertension	1.69e-07	1.41e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTEN—hypertension	1.58e-07	1.31e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—EP300—hypertension	1.5e-07	1.25e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AKT1—hypertension	1.47e-07	1.23e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AKT1—hypertension	1.39e-07	1.16e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AKT1—hypertension	9.08e-08	7.57e-07	CbGpPWpGaD
